Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
540.00    -13.00 (-2.35%)
Bid:
541.00
Ask:
543.00
Spread: 2.00 (0.37%)
Market Cap: £995.07m
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

New Ordinary Shares issued

7 Dec 2010 07:00

RNS Number : 4714X
Volex Group PLC
07 December 2010
 



For Immediate Release

December 7 2010

 

Volex Group PLC

 

New Ordinary Shares issued under the Volex Group plc 2010 Joint Share Ownership Plan; PDMR Notice

 

Volex Group plc (the "Company") announces that on 6 December 2010 it issued 775,000 new ordinary shares of 25 pence each ("Ordinary Shares") at a price of 25p per share upon and subject to the terms of the Volex Group plc 2010 Joint Share Ownership Plan ("JSOP"). Of the newly-issued Ordinary Shares, 600,000 Ordinary Shares are being issued to Andrew Cherry, the Company's Group Finance Director, and the remaining 175,000 Ordinary Shares are being issued to another employee of the Company, in each case jointly with the trustee of the Volex Group Guernsey Purpose Trust (the "Trust").

 

The 775,000 new Ordinary Shares rank in full for all dividends and other distributions made, paid or declared after their date of issue and otherwise pari passu in all respects with the existing issued Ordinary Shares. The Company has applied to the UK Listing Authority for the listing of, and to the London Stock Exchange for the admission of, these shares to the Official List and to trading on the London Stock Exchange's Main Market for listed securities.

 

Following this award, Andrew Cherry holds total conditional share awards over 905,623 Ordinary Shares. In addition, he holds 41,765 Ordinary Shares.

 

Joint Share Ownership Plan

 

The JSOP provides for the acquisition by employees, including Executive Directors, of beneficial interests in Ordinary Shares, which are held jointly with the Trust upon the terms of a Joint Ownership Agreement (the "JOA"). The terms of a JOA provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the Trust receives the market value of the jointly owned shares at the date of their issue ("IMV") plus an amount representing notional interest on the IMV from the date of issue to the date of sale ("the carrying cost"), and the employee is entitled to the balance (if any). It is a further term of each JOA that the employee may, in certain circumstances, acquire the Trustee's interest in the jointly owned shares for a consideration equal to the par value of the jointly owned shares (namely 25p per share). Jointly owned shares vest if the employee remains employed within the Volex group of companies for a specified minimum period and performance targets relating to growth in share price are met.

 

The jointly owned shares have been issued jointly to each individual and the Trust at an aggregate price equal to their par value of 25p per share. The closing price of a share in the Company on 6 December 2010 was 335.0p. Of the aggregate subscription monies for the shares jointly owned by Mr. Cherry and the Trust, totalling £150,000, Mr. Cherry has paid £600, with the balance of his jointly owned interest having been paid by the Trust out of monies advanced by way of loan to the Trust by the Company.

 

Disclosure and Transparency Rules

 

In accordance with the FSA's Disclosure and Transparency Rules, as at 6 December 2010 after taking into account the 775,000 Ordinary Shares issued earlier today, the Company's issued ordinary share capital comprises 62,493,578 ordinary shares of 25p with voting rights.

 

The above figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

 

Volex Group PLC

 

Ray Walsh, Group Chief Executive

+44 20 3370 8833

Andrew Cherry, Group Finance Director

+44 20 3370 8833

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNARRRVAURUA
Date   Source Headline
25th Jun 20267:00 amRNSPreliminary Group Results FY2026
25th Jun 20267:00 amRNSUpdate on Move to the Main Market
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.